COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study

COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study

The purpose of the study is to analyze the impact of vaccination against SARS-CoV-2 on anxiety and depression scores in patients with different modalities of chronic kidney disease. One hundred and seventeen renal patients (50 hemodialysis patients, 13 peritoneal dialysis patients, 32 kidney transpl...

Full description

Saved in:
Bibliographic Details
Published in:Vaccines (Basel) Vol. 10; no. 2; p. 299
Main Authors: Garcia-Llana, Helena, Panizo, Nayara, Gandía, Lorena, Orti, Marisa, Giménez-Civera, Elena, Forquet, Claudia, D'Marco, Luis, Puchades, Maria Jesús, Sargsyan, Mari, Sanchís, Irina, Ribera, Carmen, Marco, Mª Inés, Ferrá, Cristela Moncho, Pérez-Baylach, Carmen María, Bonilla, Begoña, Moncho Francés, Francesc, Perez-Bernat, Elisa, Sancho, Asunción, Górriz, Jose Luis
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 16-02-2022
MDPI
Subjects:
Anxiety
Chronic illnesses
chronic kidney disease
Coronaviruses
COVID-19
COVID-19 vaccines
Dialysis
Hemodialysis
Hospitals
Immunization
Impact analysis
Kidney diseases
Kidney transplantation
Mental depression
Mortality
Nephrology
Pandemics
Patients
Peritoneal dialysis
Population
psychological distress
Psychological stress
Psychology
Quality of life
Quantitative psychology
Questionnaires
Severe acute respiratory syndrome coronavirus 2
Signs and symptoms
Sociodemographics
Statistical analysis
Transplants
Transplants & implants
Vaccination
Vaccines
Variables
Viral diseases
COVID-19
chronic kidney disease
psychological distress
vaccination
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The purpose of the study is to analyze the impact of vaccination against SARS-CoV-2 on anxiety and depression scores in patients with different modalities of chronic kidney disease. One hundred and seventeen renal patients (50 hemodialysis patients, 13 peritoneal dialysis patients, 32 kidney transplants, and 22 advanced chronic kidney disease patients at pre-dialysis care) were evaluated for depression, anxiety, health-related quality of life (HRQOL), and perceived fears and resources with standardized (Hospital Anxiety and Depression Scale (HADS)) and self-reported questionnaires. The measure points were before vaccination and 15 days after vaccination. The main finding of the study was that there was a decrease in the global mean of normal scores for anxiety and depression symptoms in chronic kidney disease patients post-vaccination. We did not find statistically significant differences in depression or anxiety scores, nor any HRQOL differences between the treatment groups. The three main fears reported by the participants at baseline were those of adverse effects, not getting the vaccine, and lack of information. These findings highlight the potential interest of assessing psychological variables related to the impact of vaccination against SARS-CoV-2. New studies will be required to assess the impact of comprehensive vaccine coverage and its psychological impact.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2076-393X
2076-393X
DOI:10.3390/vaccines10020299